IRL versus IBG, page-25

From what I read on other threads involving multiple companies it probably isn't great to spend 2015 in a urinating competition between IRL and IBG. There's nothing to gain. Both companies share zinc as their central resource , and thereafter the differences are numerable ; from sovereign domain to balance sheet. We could discuss each or all ad finitum to no end benefit.

So respectfully I'll bow out of future commentary on this thread as I'm only invested in one company and not both. IBG looks set to increase in value IMO. I hope both companies return to their shareholders a healthy return. All the best.